Citations

Clear

36 citation(s) found for "McDonald, John WD".

Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn’s Disease
Khanna, Reena , Feagan, Brian G. , Stitt, Larry, McDonald, John WD, Bressler, Brian , Panaccione, Remo , Shackelton, Lisa M. , VanViegen, Tanja, Jairath, Vipul , D’Haens, Geert , Sandborn, William J. , Jairath, Vipul , Jairath, Vipul , Panaccione, Remo , D'Haens, G , Jairath, V , Jairath, V , Jairath, Vipul , Zou, Guangyong , Loftus, Edward V. , Daperno, Marco

Mayo Clinic

Inflammatory Bowel Diseases | April 25, 2024 | Volume: 31 | Issue: 3 | Pages: 706-715

10.1093/ibd/izae089 | PMID 38661492 Get It

Abstract Background Regulatory guidance for Crohn’s disease trials recommends coprimary efficacy end points that evaluate both symptoms and mucosal inflammation. We aimed to characterize the operating properties of commonly used disease activity assessments alone and in combination. Methods Endoscopic and clinical data were available for 129 participants from the Study of Biologic and Immunomodulator Naïve Patients in Crohn’s Disease trial. Readers scored the Simple Endoscopic Score for Crohn’s Disease and the Crohn’s Disease Endoscopic Index of Severity using standardized conventions. Index reliability was determined using intraclass correlation coefficients. Index responsiveness was assessed using standardized effect sizes based upon treatment assignment. Outcomes were evaluated for optimal sensitivity to treatment effect. Results Substantial inter-rater reliability was observed when the Simple Endoscopic Score for Crohn’s Disease and Crohn’s Disease Endoscopic Index of Severity were used as continuous measures (intraclass correlation coefficient, 0.64; 95% confidence interval [CI], 0.50-0.73; and 0.62 95% CI, 0.36-0.77) compared with moderate reliability when dichotomized (0.46; 95% CI, 0.26-0.65; and 0.51; 95% CI, 0.00-0.78). The Simple Endoscopic Score for Crohn’s Disease, Crohn’s Disease Endoscopic Index of Severity, patient-reported outcome-2, and Crohn’s Disease Activity Index were similarly responsive (standardized effect size, 0.43, 95% CI, 0.05-0.81; 0.38, 95% CI, 0.0-0.76; 0.53, 95% CI, 0.15-0.91). A composite outcome of Crohn’s Disease Activity Index score <150 and Crohn’s Disease Endoscopic Index of Severity score <6 was most sensitive to treatment effect (28.9%; 95% CI, 11.0%-46.8%; P = .003). Conclusion Endoscopic indices were more reliable as continuous measures. Composite outcomes including endoscopy improved sensitivity to treatment effect.
Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study
Battat, Robert , Pai, Rish K. , Wang, Zhongya , Zou, Guangyong , McDonald, John WD, Duijvestein, Marjolijn , Jeyarajah, Jenny , Parker, Claire E. , Viegen, Tanja van, Nelson, Sigrid, Boland, Brigid S. , Singh, Siddharth , Dulai, Parambir S. , Feagan, Brian G. , Sandborn, William J. , Pai, R K , Jeyarajah, Jenny , Parker, Claire E , Singh, S , Dulai, Parambir S , Feagan, B G , Jairath, V , Sandborn, W J , Zou, Guangyong , Casteele, Niels Vande , Valasek, Mark A. , Jairath, Vipul

Mayo Clinic

Alimentary Pharmacology & Therapeutics | September 4, 2023 | Volume: 52 | Issue: 10 | Pages: 1574-1582

10.1111/apt.16083 | PMID 32981088 Get It

SummaryBackgroundThe optimal ulcerative colitis biopsy protocol is unclear.AimTo evaluate the number of biopsies required to accurately assess microscopic disease activity in ulcerative colitisMethodsBiopsies from patients with ≥4 rectosigmoid samples, and clinical and endoscopic data, were retrospectively obtained from a prospective biobank. Histology and endoscopic videos were read blindly. A 4‐biopsy Robarts Histopathology Index (RHI) reference score, consisting of the worst item‐level ratings from four biopsies, was compared to 1‐, 2‐ and 3‐biopsy estimates. Agreement was determined using bivariate errors‐in‐variable regression analysis (acceptance interval: ±8.25). Endoscopic activity and disease location subgroup analyses were also performed.ResultsForty‐six patients had ≥4 rectosigmoid biopsies available (N = 287). The 2‐biopsy (tolerance interval: −7.66, 4.79) and 3‐biopsy (tolerance interval: −4.86, 3.46) RHI scores demonstrated acceptable agreement with 4‐biopsy scores. One‐biopsy scores demonstrated unacceptable agreement (tolerance interval: −13.99, 7.78). Mean RHI scores using the 2‐, 3‐ and 4‐biopsy approaches were similar (6.1 ± 9.6 P = 0.36; 6.8 ± 10.5, P = 0.7; 7.5 ± 11.2), whereas the 1‐biopsy estimate was lower (4.4 ± 8.1, P = 0.06). Histological remission rates were identical for the 2‐, 3‐ and 4‐biopsy methods (65.2%, P = 1.0). Subgroup analysis demonstrated that three biopsies were required in patients with endoscopically active disease. Sampling additional colonic locations yielded lower histological remission rates compared to rectosigmoid sampling alone (33.3% vs 61.9%, P = 0.1).ConclusionsA minimum of two — conservatively, three — biopsies are required to reliably assess disease activity in a single colonic segment using the RHI. Further studies are needed of endoscopically active patients and sampling locations. These results have implications for biopsy strategies in clinical trials and practice.
Comprehensive review: Frailty in pancreas transplant candidates and recipients
Parsons, Ronald F. , Tantisattamo, Ekamol , Cheungpasitporn, Wisit , Basu, Arpita , Lu, Yee , Lentine, Krista L. , Woodside, Kenneth J. , Singh, Neeraj , Scalea, Joseph R. , Alhamad, Tarek , Rivera, Franco H. Cabeza , Parajuli, Sandesh , Pavlakis, Martha , Cooper, Matthew , Scalea, Joseph , Dunn, Ty B , Cabeza Rivera, Franco H , Parajuli, Sandesh , Pavlakis, Martha , Cooper, Matthew , Cheungpasitporn, Wisit , Basu, Arpita , Tantisattamo, Ekamol , Woodside, Kenneth , Alhamad, Tarek , Lu, Yee

Mayo Clinic

Clinical Transplantation | January 2, 2023 | Volume: 37 | Issue: 2 | Pages: No page available

10.1111/ctr.14899 | PMID 36591953 Get It

AbstractWell‐selected patients with kidney disease and diabetes mellitus who undergo simultaneous kidney‐pancreas transplantation often experience dramatic improvements in quality of life and long‐term survival compared to those who remain on medical therapy. Over the past several years the importance of frailty in the pancreas transplant candidate and recipient populations has grown. More patients with advanced age have entered the waitlist, and complications from prolonged diabetes, even in younger patients, have created increased evidence of risk for frailty. Given these concerns, and the broad challenges facing pancreas transplantation volumes overall, we generated this review to help establish the impact and implications. We summarize the interplay of immunological factors, aging, environmental factors, diabetes mellitus, and chronic kidney disease that put these patients at risk for frailty. We discuss its measurement and recommend a combination of two instruments (both well‐validated and one entirely objective). We describe the outcomes for patients before and after pancreas transplantation who may have frailty, and what interventions can be taken to mitigate its effects. Broader investigation into frailty in the pancreas transplant population is needed to better understand how to select patients for pancreas transplantation and to how manage its consequences thereafter.
Pancreas transplantation perceptions and practice: Results from a national US survey
Parsons, Ronald F. , Matar, Abraham J. , Lentine, Krista L. , Woodside, Kenneth J. , Singh, Neeraj , Alhamad, Tarek , Basu, Arpita , Rivera, Franco H. Cabeza , Cheungpasitporn, Wisit , Romeo, Giulio R. , Rao, Swati , Kensinger, Clark D. , Parajuli, Sandesh , Tantisattamo, Ekamol , Pavlakis, Martha , Cooper, Matthew , Matar, Abraham J. , Matar, Abraham , Cabeza Rivera, Franco H , Romeo, Giulio , Sultan, Samuel , Tantisattamo, Ekamol , Pavlakis, Martha , Cooper, Matthew , Cheungpasitporn, Wisit , Basu, Arpita , Woodside, Kenneth , Alhamad, Tarek

Mayo Clinic

Clinical Transplantation | July 22, 2021 | Volume: 35 | Issue: 10 | Pages: No page available

10.1111/ctr.14432 | PMID 34291503 Get It

AbstractBackgroundDue to a substantial decline in pancreas transplantation (PT) across the United States over the past 15 years, we sought to understand the perceptions and practices of US PT programs.MethodsSurveys were sent to members of the American Society of Transplantation Surgeons and the American Society of Transplantation by email and professional society postings between August 2019 and November 2019.ResultsOne hundred twenty three responses were recorded from 56 unique programs. Program characteristics were obtained from the Scientific Registry of Transplant Recipients. Respondents were transplant surgeons (71%), transplant nephrologists (17%), trainees (9%), and allied professionals (3%). Programs were defined according to annual volume as: low (<5 PT/year), intermediate (6–20), or high (>20). High‐volume programs reported that these factors were most important for increased PT: expansion of recipient selection, more aggressive donor utilization, and hiring of PT program‐specific personnel. At both the program and national level, the vast majority (82% and 79%, respectively) felt the number of PTs currently performed are not in balance with patients' needs.ConclusionsOverall, programs reported that the option of PT is not offered adequately to diabetic patients and that strategies to maintain higher PT volume are most evident at intermediate, and especially, high‐volume programs.
A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects
Itin, Ahuva, McDonald, John A., Carmeliet, Peter , Keshet, Eli , Dor, Yuval , Camenisch, Todd D. , Fishman, Glenn I.

Mayo Clinic

Development | April 26, 2021 | Volume: 128 | Issue: 9 | Pages: 1531-1538

10.1242/dev.128.9.1531 | PMID 11290292 Get It

ABSTRACT Normal cardiovascular development is exquisitely dependent on the correct dosage of the angiogenic growth factor and vascular morphogen vascular endothelial growth factor (VEGF). However, cardiac expression of VEGF is also robustly augmented during hypoxic insults, potentially mediating the well-established teratogenic effects of hypoxia on heart development. We report that during normal heart morphogenesis VEGF is specifically upregulated in the atrioventricular (AV) field of the heart tube soon after the onset of endocardial cushion formation (i.e. the endocardium-derived structures that build the heart septa and valves). To model hypoxia-dependent induction of VEGF in vivo, we conditionally induced VEGF expression in the myocardium using a tetracycline-regulated transgenic system. Premature induction of myocardial VEGF in E9.5 embryos to levels comparable with those induced by hypoxia prevented formation of endocardial cushions. When added to explanted embryonic AV tissue, VEGF fully inhibited endocardial-to-mesenchymal transformation. Transformation was also abrogated in AV explants subjected to experimental hypoxia but fully restored in the presence of an inhibitory soluble VEGF receptor 1 chimeric protein. Together, these results suggest a novel developmental role for VEGF as a negative regulator of endocardial-to-mesenchymal transformation that underlies the formation of endocardial cushions. Moreover, ischemia-induced VEGF may be the molecular link between hypoxia and congenital defects in heart septation.
Regulation of expression of fibronectin and its receptor, α5β1, during development and regeneration of peripheral nerve
Lefcort, Frances , Venstrom, Kristine, McDonald, John A., Reichardt, Louis F.

Mayo Clinic

Development | April 25, 2021 | Volume: 116 | Issue: 3 | Pages: 767-782

10.1242/dev.116.3.767 | PMID 1289065 Get It

ABSTRACT The extracellular matrix glycoprotein, fibronectin, is a potent promoter of peripheral neurite outgrowth. Interactions of peripheral neurons with fibronectin have been shown to be primarily mediated by the β1 class of integrin heterodimers. In the present study, we have examined the expression and regulation of fibronectin and its integrin receptor, α5 β1, in developing and regenerating chick peripheral nerve. We show that fibronectin and α5β1 α5β1 are expressed at comparatively high levels in developing nerve with α5β1 expression on axons and non-neuronal cells. With nerve maturation, both proteins are less prominently expressed and the cellular pattern of α5β1,expression becomes more restricted. Following lesion of mature nerve, both fibronectin and α5β1, are strongly induced with prominent expression of α5β1, on regenerating neurites and Schwann cells. The elevation in fibronectin levels in the regenerating nerve is highest in the vicinity of the lesion, an area undergoing extensive cellular remodeling including Schwann cell migration and growth cone extension. Our results suggest that fibronectin and its receptor, α5β1, may mediate functionally important interactions in the development and regeneration of peripheral nerve.
A novel role for α3β1 integrins in extracellular matrix assembly
Wu, Chuanyue , Chung, Albert E., McDonald, John A.

Mayo Clinic

Journal of Cell Science | April 25, 2021 | Volume: 108 | Issue: 6 | Pages: 2511-2523

10.1242/jcs.108.6.2511 | PMID 7673365 Get It

ABSTRACT To study the biological role of α3β1 integrins in cell adhesion, migration, and in the deposition of extracellular matrix, we stably expressed the human α3 integrin subunit in the α4, α5 integrin deficient CHO cell line B2. The expression of α3β1 integrins enhanced cell adhesion on entactin (also known as nidogen), but not on fibronectin. Using recombinant GST-fusion proteins that span the entire length of the entactin molecule, we located cell adhesive activity to the G2 domain of entactin. These results suggest that the α3β1 integrin functions as an adhesion receptor interacting with the G2 domain of entactin. On the other hand, the expression of α3β1 integrins did not confer the ability to migrate on entactin. Strikingly, the expression of α3β1 dramatically increased the deposition of entactin and fibronectin into the pericellular matrix. This was accompanied by increased binding activity of the 29 kDa amino-terminal domain of fibronectin. Thus, similar to α5β1 integrins, α3β1 integrins can play an important role in modulating the assembly of pericellular matrices. However, unlike fibronectin deposition supported by α5β1, α3β1 supported fibronectin deposition into pericellular matrix was not inhibited by antibodies binding to the RGD containing cell adhesion domain of fibronectin, demonstrating that the two processes are mechanistically distinct. The role of α3β1 in pericellular matrix assembly potentially implicates this receptor in the assembly and/or recognition of entactin-containing pericellular matrices, an observation consistent with its apparent role in the renal glomerulus of the mammalian kidney.
the role of α4β1 integrin in cell motility and fibronectin matrix assembly
Wu, Chuanyue , Fields, Andrew J. , Kapteijn, Barbara A. E., McDonald, John A.

Mayo Clinic

Journal of Cell Science | April 25, 2021 | Volume: 108 | Issue: 2 | Pages: 821-829

10.1242/jcs.108.2.821 | PMID 7539441 Get It

ABSTRACT The α4β1 integrin has been suggested to play important roles in embryogenesis and pathogenesis of many diseases which involve both cell adhesion and cell migration. Previous studies using anti-α4β1 antibodies and fibronectin (Fn) fragments have suggested that α4β1 integrins may be involved in cell motility on Fn and vascular cell adhesion molecule-1 (VCAM-1). However, the cells used in these studies also express other Fn integrin receptors including α5β1 integrin, which is known to function in cell motility on Fn. To test whether α4β1 integrins mediate cell motility on Fn and VCAM-1 in the absence of α5β1 integrin, we expressed human α4 integrin in a Chinese hamster ovary (CHO) cell line that is deficient in α5β1 integrin (CHO B2). The parental α5 deficient CHO B2 cells were unable to adhere, spread or migrate on Fn, nor could they assemble a fibrillar Fn matrix. Expression of α4β1 integrin in the CHO B2 cells enabled the cells to adhere, spread and migrate on Fn and on VCAM-1 but not to assemble a fibrillar Fn matrix. The cellular processes mediated by the interaction of α4β1 with Fn or VCAM-1 were inhibited by the CS1 peptide derived from the major α4β1 binding site on Fn. These findings demonstrate that α4β1 integrins not only function as cell adhesion receptors but also as cell motility receptors for Fn and VCAM-1 independent of α5β1. Moreover, they reveal important functional differences between Fn binding integrins. The α4-positive, α5-negative CHO cells described in this report will be useful tools in studying the mechanism of molecular signalling during integrin mediated cellular processes.
S0662 Evaluating the Optimum Number of Biopsies to Assess Histologic Inflammation in Ulcerative Colitis
Pai, Rish K. , Wang, Zhongya , McDonald, John WD, Duijvestein, Marjolijn , Jeyarajah, Jenny , Parker, Claire E. , Viegen, Tanja van, Nelson, Sigrid, Boland, Brigid S. , Singh, Siddharth , Dulai, Parambir S. , Feagan, Brian G. , Sandborn, William J. , Battat, Robert , Casteele, Niels Vande , Zou, Guangyong , Valasek, Mark A. , Jairath, Vipul

Mayo Clinic

American Journal of Gastroenterology | October 24, 2020 | Volume: 115 | Issue: 1 | Pages: S331-S332

10.14309/01.ajg.0000704696.77507.99 Get It

Use of Combined Electroencephalography and Tilt Table Testing to Determine Etiology of Loss of Consciousness
Singh, Neeraj , Lynch, Timothy M., Ritaccio, Anthony , Lynch, Timothy

Mayo Clinic

The Neurodiagnostic Journal | February 26, 2020 | Volume: 60 | Issue: 1 | Pages: 36-40

10.1080/21646821.2020.1716605 | PMID 32101108 Get It